Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
25-2
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
25-2
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #47177
advertisement
Kim M
14
Showing records 1 to 14 |
Display all abstracts from
Kim M
125392
Comparison of Efficacy and Ocular Surface Assessment Between Preserved and Preservative-Free Brimonidine/Timolol Fixed-Combination Eye Drops in Glaucoma Patients: A Parallel-Grouped, Randomized Trial
Kim M
Journal of clinical medicine
2025; 14:
125853
How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Kim M
Pharmaceutics
2024; 16:
126848
Protocol for a systematic review and network meta-analysis comparing the efficacy and safety of benzalkonium chloride-preserved, alternatively preserved and preservative-free eyedrops in the treatment of glaucoma
Kim M
BMJ open
2025; 15: e085303
125853
How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Jung MY
Pharmaceutics
2024; 16:
126848
Protocol for a systematic review and network meta-analysis comparing the efficacy and safety of benzalkonium chloride-preserved, alternatively preserved and preservative-free eyedrops in the treatment of glaucoma
Kim YK
BMJ open
2025; 15: e085303
125392
Comparison of Efficacy and Ocular Surface Assessment Between Preserved and Preservative-Free Brimonidine/Timolol Fixed-Combination Eye Drops in Glaucoma Patients: A Parallel-Grouped, Randomized Trial
Lee CK; Shin J
Journal of clinical medicine
2025; 14:
125853
How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Lee DY
Pharmaceutics
2024; 16:
126848
Protocol for a systematic review and network meta-analysis comparing the efficacy and safety of benzalkonium chloride-preserved, alternatively preserved and preservative-free eyedrops in the treatment of glaucoma
Rho S
BMJ open
2025; 15: e085303
125392
Comparison of Efficacy and Ocular Surface Assessment Between Preserved and Preservative-Free Brimonidine/Timolol Fixed-Combination Eye Drops in Glaucoma Patients: A Parallel-Grouped, Randomized Trial
Kim D
Journal of clinical medicine
2025; 14:
125853
How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Ahn SM
Pharmaceutics
2024; 16:
126848
Protocol for a systematic review and network meta-analysis comparing the efficacy and safety of benzalkonium chloride-preserved, alternatively preserved and preservative-free eyedrops in the treatment of glaucoma
Ha A
BMJ open
2025; 15: e085303
125853
How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Lee GM
Pharmaceutics
2024; 16:
125392
Comparison of Efficacy and Ocular Surface Assessment Between Preserved and Preservative-Free Brimonidine/Timolol Fixed-Combination Eye Drops in Glaucoma Patients: A Parallel-Grouped, Randomized Trial
Rho S
Journal of clinical medicine
2025; 14:
125853
How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Park CY
Pharmaceutics
2024; 16:
Issue
25-2
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept